List of SJS-inducing substances
This is a list of drugs and substances that are known or suspected to cause Stevens–Johnson syndrome .
^ Harr T, French LE (2012). "Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis". Adverse Cutaneous Drug Eruptions . Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Vol. 97. pp. 149– 166. doi :10.1159/000335627 . ISBN 978-3-8055-9970-2 . PMID 22613860 .
^ a b c d "Stevens Johnson Syndrome" . WebMD.
^ See, e.g.: Schultz, Laura (December 28, 2015). "Potential Zithromax Side Effects Include Stevens Johnson Syndrome" . Top Class Actions, LLC. Archived from the original on March 4, 2016. Retrieved December 28, 2015 . Several Zithromax lawsuits have been filed against Pfizer alleging that the drug maker failed to warn the medical community and the public about serious risks associated with taking the antibiotic.
^ Mamishi, Setareh; Fattahi, Fatemeh; Pourpak, Zahra; Aghaee, Farzaneh Mirza; Moinfar, Zeinab; Mohammadi, Mahmoud; Ashrafi, Mahmoud; Moin, Mostafa (2009-11-01). "Severe cutaneous reactions caused by barbiturates in seven Iranian children" . International Journal of Dermatology . 48 (11): 1254– 1261. doi :10.1111/j.1365-4632.2007.03561.x . ISSN 1365-4632 . PMID 20064188 . S2CID 10117062 .
^ a b c Rehmus, Wingfield E (November 2013). "Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN)" . Merck Manual . Merck Sharp & Dohme Corp.
^ Wu, Ming-Kung; Chung, Weilun; Wu, Ching-Kuan; Tseng, Ping-Tao (2015-01-01). "The severe complication of Stevens-Johnson syndrome induced by long-term clozapine treatment in a male schizophrenia patient: a case report" . Neuropsychiatric Disease and Treatment . 11 : 1039– 1041. doi :10.2147/NDT.S79327 . ISSN 1176-6328 . PMC 4399514 . PMID 25914536 .
^ a b Mockenhaupt, Maja; Viboud, Cecile ; Dunant, Ariane; Naldi, Luigi; Halevy, Sima; Bavinck, Jan Nico Bouwes; Sidoroff, Alexis; Schneck, Jürgen; Roujeau, Jean-Claude; Flahault, Antoine (2008-01-01). "Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-Study" (PDF) . Journal of Investigative Dermatology . 128 (1): 35– 44. doi :10.1038/sj.jid.5701033 . ISSN 0022-202X . PMID 17805350 .
^ Roujeau, J.-C., Kelly, J. P., Naldi, L., Rzany, B., Stern, R. S., Anderson, T., Auquier, A., Bastuji-Garin, S., Correia, O., Locati, F., Mockenhaupt, M., Paoletti, C., Shapiro, S., Shear, N., Schopf, E., Kaufman, D. W. (1995). "Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis" . N Engl J Med . 333 (1): 1600– 1607. doi :10.1056/NEJM199512143332404 . PMID 7477195 . {{cite journal }}
: CS1 maint: multiple names: authors list (link )
^ "Safety of off label use of Glutathione Injection" (PDF) .
^ Raksha MP, Marfatia YS (2008). "Clinical study of cutaneous drug eruptions in 200 patients" . Indian J Dermatol Venereol Leprol . 74 (1): 80. doi :10.4103/0378-6323.38431 . hdl :1807/48058 . PMID 18193504 .
^ Medsafe Data Sheet Archived 2007-09-28 at the Wayback Machine March 8, 2005. Accessed April 26, 2007.
^ "LAMICTAL PRESCRIBING INFORMATION" (PDF) . GlaxoSmithKline. Archived from the original (PDF) on 2006-09-13. Retrieved 2009-12-17 .
^ "PROVIGIL PRESCRIBING INFORMATION" (PDF) . Cephalon, Inc. Archived from the original (PDF) on 2015-05-01.
^ "Norfloxacin" (PDF) . Davis. 2017. Archived from the original (PDF) on October 27, 2017. Retrieved March 24, 2017 .
^ Khawaja A, Shahab A, Hussain SA (May 2012). "Acetaminophen-induced Steven Johnson syndrome-toxic epidermal necrolysis overlap". J Pak Med Assoc . 62 (5): 524– 7. PMID 22755330 .
^ "Stevens-Jonhson syndrome after acetaminophen ingestion, confirmed by challenge test in an eleven-year-old patient" . the Journal: Allergologia et Immunopathologia.
^ "Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)" (PDF) (data sheet). European Medicines Agency . 6 April 2017.